Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion Johnson & Johnson (J&J) announced on Monday its $14.6 billion acquisition of neurological drugmaker Intra-Cellular Therapies, marking its largest deal in over two
